ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 104

Incremental Direct Expenditures Due to Osteoarthritis: A Nationally Representative Study Using Medical Expenditure Panel Survey Data

Jyothi Menon, Purdue University, West Lafayette, IN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Health care cost, ICD-9, osteoarthritis and outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Health Services Research - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Osteoarthritis is characterized by symptoms related to abnormalities in joints, subchondral bones and periarticular structures. In the United States, it was estimated that twenty-seven million adults suffered from osteoarthritis in 2005. The objectives of this study were to determine incremental health care resource utilization and incremental health care expenditures, associated with Osteoarthritis.

Methods: An observational database analysis was conducted using information from the Medical Expenditure Panel Survey (MEPS). Individuals 18 years of age or older and employed during 2011 were eligible for inclusion in the sample for analyses. Individuals were identified with Osteoarthritis diagnosis based on ICD-9-CM diagnosis codes. Out of a sample of 26,992 individuals, 1,354 were diagnosed with osteoarthritis. Using sampling weights provided, individuals with osteoarthritis were compared to individuals without osteoarthritis on health care resource utilization and expenditures.

Results: Compared to individuals with osteoarthritis, significantly lower mean unadjusted hospitalizations (0.24 v 0.09, p<0.001), mean unadjusted outpatient room visits (12.93 v 4.89, p<0.001) and mean unadjusted emergency room visits (0.33 v 0.22, p<0.001) were observed among those without osteoarthritis. Compared to individuals with osteoarthritis, significantly lower mean unadjusted inpatient expenditures ($3,563 v $1,1,91 p<0.001), mean unadjusted outpatient expenditures ($3,242 v $1,223, p<0.001), mean unadjusted emergency room expenditures ($295 v $ 187, p<0.001), and mean unadjusted medication expenditures ($2,336 v $962, p<0.001) and mean unadjusted total expenditure ($9651 v $3,415, p<0.001) were observed among those without osteoarthritis. Incremental health care resource utilization examined included annual hospitalization, annual hospital days, annual emergency room visits, annual outpatient visits. Incremental health expenditures examined included annual inpatient expenditures, annual outpatient expenditures, annual emergency room expenditures, annual miscellaneous expenditures, annual medication expenditures and annual total expenditures. Incremental resource utilization and incremental resource expenditures were estimated using regression models, adjusting for other covariates including age, gender, sex, region, marital status, insurance coverage, comorbidities, anxiety, asthma, hypertension and hyperlipidemia. Multivariate regression models revealed incremental mean annual resource use associated with osteoarthritis of 70 additional hospitalizations per 100 osteoarthritic patients annually, and 363 additional visits per 100 osteoarthritic patients annually. Mean annual incremental total expenditures associated with osteoarthritis were $2,046. Mean annual incremental expenditures were largest for inpatient expenditures at $826, followed by mean annual incremental outpatient expenditures of $659, and mean annual incremental medication expenditures of $325.

Conclusion: Osteoarthritis was associated with considerable incremental health care resource utilization and expenditures.


Disclosure: J. Menon, None;

To cite this abstract in AMA style:

Menon J. Incremental Direct Expenditures Due to Osteoarthritis: A Nationally Representative Study Using Medical Expenditure Panel Survey Data [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/incremental-direct-expenditures-due-to-osteoarthritis-a-nationally-representative-study-using-medical-expenditure-panel-survey-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incremental-direct-expenditures-due-to-osteoarthritis-a-nationally-representative-study-using-medical-expenditure-panel-survey-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology